Abstract:Background: 5-Hydroxytryptamine receptor (5-HTR) and 5-hydroxytryptamine transporter (5-HTT) gene polymorphisms have been reported to be associated with susceptibility to obstructive sleep apnea syndrome (OSAS). The associations, derived from sporadic, inconsistent, small-sample-size studies, need to be evaluated further in a meta-analysis. Methods: Relevant studies were identified by searching PubMed, Embase, The Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang, and Weipu. Eligible data were extracted from each included study. Odds ratios (ORs) were calculated using a fixed-effects or a random-effects model. The ORs and 95% confidence interval (CI) were used to assess the strength of the association between serotonergic gene polymorphisms and OSAS in the dominant and recessive models, as well as alleles. The Q statistic was used to evaluate homogeneity and Begg's test was used to assess publication bias. Results: Eight studies were finally included in the meta-analysis of the association between 5-HTR2A gene variants (including 102T/C and 1438G/A), 5-HTT gene polymorphisms (including 5-HTT gene-linked promoter region (5-HTTLRP), and serotonin transporter intron 2 variable number tandem repeat (STin2VNTR) and OSAS risk. The G allele of 5-HTR2A 1438G/A, long 5-HTTLPR, and 10-tandem-repeats STin2VNTR were shown to increase OSAS susceptibility, with ORs of 2.33 (A vs. G, 95% CI 1.48-3.66), 1.24 (L vs. S, 95% CI: 1.04-1.49), and 2.87 (10 vs. 12, 95% CI: 1.38-5.97), respectively. These significant differences were determined in both dominant and recessive models. Of the 5-HTR2A 1438G/A gene polymorphism, the AA genotype increased the OSAS risk, with an OR of 4.21 (95% CI: 2.83-6.25) in a recessive model in male OSAS patients, but no significant association was found in females. Conclusions: Our meta-analysis demonstrated that polymorphisms in the 5-HTR2A 1438G/A and 5-HTT genes contributed to susceptibility to OSAS. The A allele of the 1438G/A gene polymorphism is predominantly distributed in males and increased the OSAS risk significantly.

The association between serotonin-related gene polymorphisms and susceptibility and early sertraline response in patients with panic disorder

Association between serotonin - related gene polymorphisms and e arly effects of sertraline in Chinese Han patients with panic disorder

Association between 5-HT1A receptor C-1019G, 5-HTTLPR polymorphisms and panic disorder: a meta-analysis

A Panel of Mirnas is Involved in the Effect of Sertraline on Panic Disorder, As Implicated by a Microarray-Based Analysis

Study on the relationship between serotonin receptor 2A gene polymorphism and clinical response to paroxetine

The Relationship of Peripheral Blood Single Uncoding RNA-25-3p Expression Level and the Sertraline Efficacy in Patients with Panic Disorder

5-Htr1a And 5-Htr2a Genetic Polymorphisms And Ssri Antidepressant Response In Depressive Chinese Patients

Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population

[Molecular Pharmacogenetic Studies of Drug Responses to Obsessive-Compulsive Disorder and Six Functional Genes].

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

Association of Serotonin Transporter Gene (5-HTTLPR/rs25531) Polymorphism with Comorbidities of Panic Disorder

Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response.

Effects of Cytochrome P450 2C19 Genetic Polymorphisms on Responses to Escitalopram and Levels of Brain-Derived Neurotrophic Factor in Patients with Panic Disorder.

Pharmacokinetics of Sertraline in Relation to Genetic Polymorphism of CYP2C19

Association of unipolar depression with gene polymorphisms in the serotonergic pathways in Han Chinese.

Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence

A systematic review and meta-analysis of the association between serotonergic gene polymorphisms and obstructive sleep apnea syndrome

Association between SLC17A7 gene polymorphisms and venlafaxine for major depressive disorder in a Chinese Han population: a prospective pharmacogenetic case-control study

A Comprehensive Assessment of Genetic Variation in Serotonin Transporter Gene (5‐httlpr+rs25531) and the Response to Dapoxetine in Chinese Patients with Premature Ejaculation

Association between 5-HT2A receptor gene polymorphism and risperidone treatment response in the first episode ( drug-naive)Chinese patients with schizophrenia

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression